Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RPL18AP7 (ribosomal protein L18a pseudogene 7) is a human processed pseudogene located on chromosome 7, annotated as a non-functional copy (retrocopied segment) originating from the parental protein-coding gene RPL18A. Like most ribosomal protein pseudogenes, RPL18AP7 does not encode a functional protein and plays no known direct role in cellular biology or disease; its presence is primarily of interest for genomic annotation and comparative genomics. There is no current evidence that RPL18AP7 has therapeutic, diagnostic, or druggable relevance, nor does it contribute to ribosomal function or protein synthesis in humans. RPL18AP7 is a non-coding pseudogene related to ribosomal protein L18a, not a functional or druggable target, with no known biological or disease relevance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L18a pseudogene 7 (RPL18AP7).